Patent details

EP1827468 Title: Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease

Basic Information

Publication number:
EP1827468
PCT Application Number:
PCT/US/2005/024656
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057712739
PCT Publication Number:
WO/2006/071274
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
French Title of Invention:
Inhibiteurs de l'acetylcholinesterase et acétate de leuprolide pour le traitement de la maladie d'Alzheimer
German Title of Invention:
Acetylcholinesterasehemmer und Leuprolidacetat zur Behandlung von Alzheimer-Krankheit
SPC Number:

Dates

Filing date:
13/07/2005
Grant date:
22/08/2012
EP Publication Date:
22/08/2012
PCT Publication Date:
06/07/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2007
EP B1 Publication Date:
22/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/07/2013
Expiration date:
13/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/07/2005
 
 

Name:
Curaxis Pharmaceutical Corporation
Address:
1004 Chagford Way, Raleigh, NC 27614, United States (US)

Inventor

1

Name:
GREGORY Christopher, W.
Address:
United States (US)

2

Name:
SMITH Patrick, S.
Address:
United States (US)

Priority

Priority Number:
638123 P
Priority Date:
23/12/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61P 25/28;
Filing date Document type Number of pages